Download PDF
1 / Pages

Other users also viewed these articles

Efficacy and safety of semaglutide in a diabetic and obese patient on incremental hemodialysis. Does it also contribute to preserving residual renal function? José Carlos de la Flor; Javier Deira; Tania Monzón; Francisco Valga; Cristina Albarracín; Elisa Ruiz; Miguel Rodeles;
Nefrologia (English Version). 2023;43:501-3
Etiopathogenesis of chronic kidney disease-associated pruritus: putting the pieces of the puzzle together Pablo Molina; Raquel Ojeda; Ana Blanco; Guillermo Alcalde; Mario Prieto-Velasco; Nuria Aresté; Juan Manuel Buades; Vicent Esteve Simó; Marian Goicoechea; Rosa Elena Pérez-Morales; Emilio Sánchez-Álvarez; Rafael Sánchez-Villanueva; María Montesa; María Dolores Arenas;
Nefrologia (English Version). 2023;43:48-62
Response to ¿Experience with dulaglutide in an obese diabetic patient on incremental peritoneal dialysis¿. Response to related letter José C. De La Flor; Esperanza Moral; Javier Deira; Tania Monzón; Francisco Valga; Cristina Albarracín; Miguel Rodeles;
Nefrologia (English Version). 2024;44:444-6